Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 7/20 | 1.00 |
| ▸ | SLC1A1 | P43005 | 6/20 | 1.00 |
| ▸ | SLC1A3 | P43003 | 5/20 | 1.00 |
| ▸ | GRIK1 | P39086 | 4/20 | 0.89 |
| ▸ | GRIK2 | Q13002 | 4/20 | 0.89 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17874870 | 1.00 | SLC1A2 (1.00) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL8764560 | 1.00 | SLC1A2 (1.00) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL2267187 | 1.00 | SLC1A2 (1.00) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL20838575 | 0.94 | SLC1A2 (1.00) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL8091382 | 0.92 | GRIK1 (1.00) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL9005462 | 0.92 | GRIK1 (1.00) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL5888741 | 0.92 | GRIK1 (1.00) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL1662288 | 0.92 | GRIK1 (1.00) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL4377664 | 0.92 | GRIK1 (1.00) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL8386178 | 0.92 | GRIK1 (1.00) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-60211452-A | — | — | None | — | — | JP | disclosed |
| EP-2801379-B1 | COATING COMPOSITION AND MEDICAL DEVICE | TERUMO CORP (JP) | 2017-03-08 | — | — | EP | disclosed |
| EP-1748805-B1 | ABSORBABLE BIOCOMPATIBLE COATINGS | BIOINTERACTIONS LTD (GB) | 2009-07-29 | — | — | EP | disclosed |
| EP-1748805-A1 | ABSORBABLE BIOCOMPATIBLE MATERIALS | Biointeractions Ltd. (GB) | 2007-02-07 | — | — | EP | disclosed |
| US-20060134166-A1 | Absorbable biocompatible materials | BIOINTERACTIONS LTD. (GB) | 2006-06-22 | — | — | US | disclosed |
| WO-2005115492-A1 | ABSORBABLE BIOCOMPATIBLE MATERIALS | BIOINTERACTIONS LTD (GB) | 2005-12-08 | — | — | WO | disclosed |
| EP-0910351-A1 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. Searle & Co. (US) | 1999-04-28 | — | — | EP | disclosed |
| EP-0907666-A1 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. Searle & Co. (US) | 1999-04-14 | — | — | EP | disclosed |
| WO-1997049736-A2 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. SEARLE AND CO. (US) | 1997-12-31 | — | — | WO | disclosed |
| WO-1997049387-A1 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. SEARLE AND CO. (US) | 1997-12-31 | — | — | WO | disclosed |
| EP-0572167-B1 | Cosmetic composition | UNILEVER PLC (GB) | 1996-10-09 | — | — | EP | disclosed |
| EP-0572167-A1 | Cosmestic composition | UNILEVER PLC (GB) | 1993-12-01 | — | — | EP | disclosed |
| US-4679911-A | Optical apparatus using liquid crystals for shaping the spatial intensity of optical beams having designated wavelengths | THE UNIVERSITY OF ROCHESTER (US) | 1987-07-14 | — | — | US | disclosed |
| US-4637896-A | CHOLESTERIC, PHOTOPOLYMERIZATION, PHOTOINITIATORS, (METH) ACRYLATE DERIVATIVES OF (DIHYDRO)CHOLESTEROL | ARMSTRONG WORLD INDUSTRIES, INC. (US) | 1987-01-20 | — | — | US | disclosed |
| US-4614619-A | Liquid crystalline materials useful to prepare polymeric films | ARMSTRONG WORLD INDUSTRIES, INC. (US) | 1986-09-30 | — | — | US | disclosed |
| JP-S60211452-A | SILVER HALIDE PHOTOSENSITIVE MATERIAL | FUJI PHOTO FILM CO LTD | 1985-10-23 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060134166-A1 | Absorbable biocompatible materials | ADM2, HDGF, SLC7A1 | SLC1A2 125/4885SLC1A1 77/4885SLC1A3 184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.